Wednesday, December 20, 2023 1:03:26 PM
While I can agree with what you're saying, I don't see how it's possible to do a critical re-evaluation prior to at least getting an update from the company on the status of many of their efforts. In the time I've been an investor, the Annual Meeting is the one time roughly yearly that we get such an update.
I don't believe this will occur until at least the UK has accepted the submission which hopefully will be made by the UK's deadline of December 25th. While I doubt any person there will handle anything submitted after tomorrow because of the holiday, it will still be determined to be on time if it's transmitted to them on or before XMAS. I suspect the company will wait for UK acceptance, announce it, and roughly simultaneously announce when they're planning on doing an Annual Meeting.
I believe the company is allowed to go a week or so into March before issuing their Annual Report, they might tie the Annual Meeting into the Annual Report, further delaying it.
Of course I could be wrong, perhaps when they announce the filing of the MAA they'll produce guidance on other things that are ongoing, anything is possible, but it hasn't been done in the past, so it's doubtful in the future.
I'm certainly no expert on the differences in what's to be filed with each country. That stated, I would think that in 1.7 million pages, only a few hundred, if that, must be substantially changed to file with different regulators. If this is the case, and if the company has told it's contractors to work on these changes, we might be very surprised to learn how quickly they intend to file with others. Of course we'll really only know this when they provide some guidance, probably at the Annual Meeting.
Gary
Recent NWBO News
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM